ALASTAIR THOMPSON to Neoplasms
This is a "connection" page, showing publications ALASTAIR THOMPSON has written about Neoplasms.
Connection Strength
0.204
-
What is the future for surgical oncology? Br J Cancer. 2011 Nov 22; 105(11):1627.
Score: 0.062
-
Dissecting the molecular mechanisms of human cancer: translating laboratory advances into clinical practice. Surgeon. 2004 Feb; 2(1):1-6.
Score: 0.036
-
The role of signal transduction in cancer treatment and drug resistance. Eur J Surg Oncol. 2002 Sep; 28(6):679-84.
Score: 0.033
-
p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer. Cancer Cell. 2013 Sep 09; 24(3):318-30.
Score: 0.018
-
Physical oncology: a bench-to-bedside quantitative and predictive approach. Cancer Res. 2011 Jan 15; 71(2):298-302.
Score: 0.015
-
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy. Oncotarget. 2010 Nov; 1(7):639-650.
Score: 0.014
-
Recessive mutation, chromosome deletion and cancer. Br J Surg. 1989 Jul; 76(7):765.
Score: 0.013
-
The p53 tumour suppressor gene. Br J Surg. 1998 Nov; 85(11):1460-7.
Score: 0.006
-
Constitutional p53 mutation in a non-Li-Fraumeni cancer family. Br J Cancer. 1992 Apr; 65(4):527-8.
Score: 0.004
-
A novel form of pRb expressed during normal myelopoiesis and in tumour-associated macrophages. Cell Prolif. 2005 Feb; 38(1):13-24.
Score: 0.002